We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: 0.25 (3.16%)
Spread: 0.70 (8.974%)
Open: 8.00
High: 8.15
Low: 7.64
Prev. Close: 7.90
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise approximately $1.15million

2 Oct 2018 07:00

RNS Number : 6138C
Tekcapital plc
02 October 2018
 

 

Tekcapital plc

 

("Tekcapital" or the "Company")

 

Placing to raise approximately $1.15 million

 

 

Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from university technology, announces today the successful placing of 11,698,335 new ordinary shares of 0.4 pence each in the Company (the "New Ordinary Shares"), at 7.5 pence per share, to raise $1.15m (£0.9 million) to fund investment in key activities and to further develop and progress with the commercialisation of its portfolio of IP technologies and for working capital purposes (the "Placing").

Key Highlights:

 

· Placing of 11,698,335 New Ordinary Shares at 7.5 pence each to raise approximately $1.15m (£0.9 million) before expenses

 

· Proceeds to be used to further develop and progress with the commercialisation of its portfolio of IP technologies

 

· Support from new investors

 

Background to the Placing and use of proceeds

 

Tekcapital is a unique intellectual property ("IP") investment and services company, specialising in the acquisition and commercialisation of technologies developed throughout a global university network of over 4,500 institutions in 160 different countries. This allows visibility of a large amount of the world's university developed IP available for acquisition, whereby through leveraging its extensive network of scientific advisors, who are able to assist in selecting and evaluating IP opportunities, Tekcapital is able to mitigate against adverse selection. In addition to the Company's University IP investment activities, the Company provides specialist services for organisations that want to acquire University IP for licensing, or to hire tech transfer expertise, in addition to providing bespoke training programs for a variety of public and private sector clients. Having demonstrated growth in Latin America, the Company believes further expansion opportunities exist in this market.

A significant amount of the Placing will be utilised to expand Tekcapital's commercialisation of their investment portfolio of businesses. The Company believes that there is considerable value to be realised from the portfolio of patent rights, and is continuing to further commercialise these operations. The Company's portfolio of investments includes:

· Belluscura plc, of which Tekcapital now owns 33.0%, and in H1 2018 reported continued progress within its advanced portable oxygen concentrator ("POC") program. Belluscara is a medical device company that acquires non-core assets from leading medical device companies and research institutions with a capable and highly experienced management. The global POC market is projected to reach a value of US$1.7bn in 2022.

 

· Lucyd ltd, which is wholly owned by Tekcapital, sells innovative smart-glasses, regular spectacles and also own exclusive license to 13 patents and one patent application for Augmented Reality ("AR") glasses. In H1 2018 Lucyd completed a Token Generation event to secure approximately $6.0m in funds, which it intends to use for the development of AR glasses. Lucyd recently launched an online store featuring latest technologies and trends in eyewear, including Lucyd-developed smartglasses, designer frames, and other innovations in spectacles.

 

· Salarius ltd, of which Tekcapital owns 97.5%, with the remaining 2.5% recently purchased by Victor Manzanilla, the new CEO of Salarius. Salarius holds a patented process for producing Nano-particle sized salt crystals, which can reduce sodium consumption by up to 50.0%. Salarius's aim is to commercialise this low-sodium Microsalt (TM) to improve the nutritional value of foods, through both a low-sodium table salt and a reduced sodium snack brand.

 

The Company will use the additional proceeds of the Placing for working capital purposes, to invest in key activities, and to further develop and progress with the commercialisation of its portfolio of IP technologies.

Details of the Placing

finnCap Ltd is acting as the Company's nominated adviser and joint broker with Novum Securities Limited in connection with the Placing.

The Placing is subject to certain Terms and Conditions. The Placing is not underwritten.

The Placing comprises 11,698,335 New Ordinary Shares. The New Ordinary Shares have been placed at the Placing Price with new investors. The Placing as a whole will raise proceeds of $1.15 million (£0.9 million), before expenses, for the Company. The New Ordinary Shares will represent approximately 22 per cent. of the enlarged issued share capital.

The New Ordinary Shares will be in registered form and capable of being held in certificated form or uncertificated form in CREST. The Placing is conditional upon the Placing Agreement becoming unconditional and Admission by no later than 8.00 a.m. on 16 October 2018 (or such time and date as the Company, finnCap and Novum may agree, being not later than 25 October 2018). The Placing is not being underwritten by either finnCap or Novum.

Application for Admission

Application will be made for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to become effective on or around 16 October 2018 ("Admission"). All Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in treasury. The total number of voting rights in the Company immediately following Admission will therefore be 54,353,042.

 

Cliff Gross PH.D, Chief Executive Officer of Tekcapital plc commented:

 

"I am pleased to announce the successful conclusion of this fundraise with support from new shareholders. The proceeds from the Placing will enable Tekcapital to continue its growth objectives and deliver further value to shareholders"

 

 

For further information please contact:

 

Tekcapital plc

Clifford M Gross, Ph.D

 

Via Walbrook PR

finnCap Ltd (Nominated Adviser and Joint Broker)

 +44 (0) 20 7220 0500

Geoff Nash (Corporate Finance)

Max Bullen-Smith (Corporate Finance)

Camille Gochez (ECM)

 

Novum Securities (Joint Broker)

Colin Rowbury

 

+44 (0) 29 7399 9427

 

Walbrook PR Ltd

 +44 (0) 20 7933 8780

Paul Cornelius / Nick Rome / Sam Allen

 tekcapital@walbrookpr.com

 

 

 

 

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 ("MAR"). In addition, market soundings (as defined in MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in MAR), as permitted by MAR. This inside information is set out in this Announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUGGWUUUPRPUG
Date   Source Headline
8th Mar 20217:00 amRNSBelluscura FDA Clearance
5th Feb 20217:00 amRNSSalarius Update
4th Feb 20212:05 pmRNSSecond Price Monitoring Extn
4th Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20212:47 pmRNSNotification of Major Shareholding
1st Feb 202111:05 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSCommencement of Trading OTCQB Venture Mkt in USA
12th Jan 20212:05 pmRNSSecond Price Monitoring Extn
12th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSLucyd -Crowdfunding and launch Lyte E glasses
21st Dec 202012:35 pmRNSHolding(s) in Company
7th Dec 20202:49 pmRNSNotification of Major Holdings
3rd Dec 20203:46 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSBelluscura Update
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSSalarius launches on Amazon North America
1st Dec 20203:19 pmRNSTotal Voting Rights
18th Nov 20202:05 pmRNSSecond Price Monitoring Extn
18th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20204:56 pmRNSNotification of Major Holdings
17th Nov 20207:00 amRNSPlacing to Raise £380,000
30th Oct 20206:08 pmRNSTotal Voting Rights
28th Oct 20207:00 amRNSLucyd Patents
5th Oct 20207:00 amRNSPortfolio Company Update: Guident Ltd
1st Oct 202010:18 amRNSExercise of Stock Options and Total Voting Rights
28th Sep 20207:00 amRNSLucyd Ecommerce management appointment
24th Sep 20207:00 amRNSSalarius Mexican Distribution Agreement
21st Sep 20207:00 amRNSGuident Files Additional Patent
16th Sep 20207:00 amRNSSalarius distribution agreement
14th Sep 20207:00 amRNSGuident Update
7th Sep 20207:00 amRNSGuident Update
27th Aug 20201:44 pmRNSGrant of Stock Options
21st Aug 20207:00 amRNSUnaudited Half-Yearly Report
27th Jul 202012:49 pmRNSResults of Annual General Mtg & Directorate Change
27th Jul 20207:00 amRNSNotice of Investor and Analyst Conference Call
22nd Jul 20207:00 amRNSLucyd Update
13th Jul 20207:00 amRNSInvestor and Analyst Conference Call
7th Jul 20201:16 pmRNSNotification of Major Holdings
30th Jun 20204:43 pmRNSNotice of AGM
17th Jun 20202:52 pmRNSNotification of Major Holdings
17th Jun 20207:30 amRNSPortfolio Company Update: Belluscura plc
16th Jun 20207:00 amRNSGuident Update
29th May 20203:18 pmRNSPosting of Annual Report & Total Voting Rights
22nd May 20201:25 pmRNSNotification of Major Shareholdings
22nd May 20207:00 amRNSGuident Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.